Académique Documents
Professionnel Documents
Culture Documents
Why Do We Care ?
ARF occurs in 5% of hospitalized patients. ARF has been found to be related to a
20% mortality rate (often infectious or cardiorespiratory) When serum creatinine increases by >3.0mg/dl, mortality approaches 40-50% and thus prompt diagnosis and institution of appropriate treatment is crucial.
What Do We Need to Do ?
First, you need to suspect acute renal
failure. Presentation of ARF:
include Malaise Hematuria Flank Pain Dyspnea
Edema
History Continued
Causes of Volume Depletion Autoimmune Disease Previous History of ARF
Physical Exam
Volume Status:
Tachycardia Mucous membranes Orthostatics Vital signs
UA Interpretation
Hyaline Casts: Not indicative of renal disease
Concentrated urine, febrile disease, poststrenuous exercise, diuretic therapy Granular Casts: Degenerating cellular casts, non-specific RBC Casts: Glomerulonephritis, vasculitis WBC Casts: Pyelonephritis, Interstitial nephritis Renal Tubular Cell Casts: Nonspecific, degenerating cellular casts Waxy casts: Chronic renal failure
Treatment
Place Foley or flush Foley if already present. As a large percentage of ARF is pre-renal, IVF
challenge appropriate in many cases. Evaluate for life-threatening complications:
A: E: (I): O: U:
Place Foley or flush Foley if already present. As a large percentage of ARF is pre-renal, IVF
challenge appropriate in most cases. Evaluate for life-threatening complications:
A: Acidemia E: Electrolyte Abnormalities (Hyperkalemia) (I: Ingestion) O: Overload (CHF) U: Uremic Encephalopathy or pericarditis ALL OF THE ABOVE ARE INDICATIONS FOR EMERGENT HEMODIALYSIS
Treatment
Treatment Continued
D/C all meds with kidney damaging potential
and adjust dosing of renally cleared meds. Monitor strict Is/Os, follow CBC to evaluate for anemia and bleeding disorders. Control hyperkalemia No longer recommended to give furosemide to convert anuric to oliguric renal failure. Consult renal for intra-renal or rapidly progressive renal failure.
An Ounce of Prevention...
Check troughs after third dose of
aminoglycosides. Use oral N-acetylcysteine or bicarbonate for contrast loads in patients with risk factors for ARF. Avoid diagnostic studies involving contrast unless absolutely necessary. Monitor Is/Os in patients with ESLD, febrile states, prolonged NPO.